Medicare Part D Beneficiaries’ Experiences with Making Complex Insurance Plan Choices: A Qualitative Interview Study [PDF]
MDM Policy & PracticeBackground. The Medicare Part D program provides stand-alone prescription drug insurance to US residents aged ≥65 y and those with disabilities.
Wändi Bruine de Bruin +3 more
doaj +2 more sources
Lessons for Medicare Part D in the hemodialysis community [PDF]
BMC Nephrology, 2006 Background Medicare beneficiaries without prescription drug coverage consistently fill fewer prescriptions than beneficiaries with some form of drug coverage due to cost.
Chertow Glenn M, Nayeem Anisa I
doaj +3 more sources
A Narrative Review of Medicare Part D Medication Therapy Management Program Design Challenges and the Development of an Evidence-Informed MTM Benefit Program for a Large Self-Insured Employer [PDF]
PharmacyThe Medicare Part D Medication Therapy Management (MTM) program has several well-documented challenges, including restrictive eligibility criteria, low patient engagement, and difficulties integrating MTM services into pharmacy workflows and broader ...
Lama Al Damen +4 more
doaj +2 more sources
Adalimumab biosimilar uptake among dermatologists in Medicare Part D through 2023: A retrospective analysis using the Prescribers – by Provider and Drug dataset [PDF]
JAAD InternationalNathan C. Schedler, BS +3 more
doaj +2 more sources
Pre-Medicare Eligible Individuals’ Decision-Making In Medicare Part D: An Interview Study [PDF]
INNOVATIONS in Pharmacy, 2010 ObjectivesThe objective of this study was to elicit salient beliefs among pre-Medicare eligible individuals regarding (1) the outcomes associated with enrolling in the Medicare Part D program; (2) those referents who might influence participants ...
Tao Jin, B.S. Pharm, Ph.D. Candidate +2 more
doaj +3 more sources
BMJ Open, 2021 Objective Benzodiazepines were excluded from Medicare Part D coverage since its introduction in 2006. Part D expanded coverage for benzodiazepines in 2013.
Minghui Li +3 more
doaj +1 more source
Exploratory Research in Clinical and Social Pharmacy, 2021 Background: Patient experience with community pharmacy services can be informed by human-centered design principles and approaches. Pharmacy services may benefit from detailed evaluations of consumer experience and patient-centered service design ...
Logan T. Murry +2 more
doaj +1 more source
JAMA, 2008 Medicare Part D Represents a bold experiment to publicly fund, but privately sell and administer, prescription drug insurance. Part D is only a relatively small part of the overall Medicare program; Medicare spent $432 billion overall in 2007, of which Part D accounted for only 11.6% ($50 billion).1 However, the Medicare program is so large that Part D
Dana P. Goldman, Geoffrey F. Joyce
openaire +1 more source
Cost-Savings and Patient Experience with a Pharmacy-Led Medicare Part D Consultation Service
INNOVATIONS in Pharmacy, 2020 Background: There are many Medicare Part D plans, making it difficult for patients to choose the optimal plan. The decision to remain on current Medicare plans is reinforced by patient inertia and uncertainty associated with plan-switching decisions.
Logan Murry +3 more
doaj +1 more source
Pharmaceutical advertising and Medicare Part D [PDF]
Journal of Health Economics, 2013 We explore how and to what extent prescription drug insurance expansions affect incentives for pharmaceutical advertising. When insurance expansions make markets more profitable, firms respond by boosting advertising. Theory suggests this effect will be magnified in the least competitive drug classes, where firms internalize a larger share of the ...
Darius, Lakdawalla +2 more
openaire +2 more sources